Short-term daily deflazacort decreases membrane permeability and increases maximum force in mdx mice
American Journal of Physiology-Cell Physiology · 2025
DOI: 10.1152/ajpcell.00187.2025 ↗Kurz gefasst
Fachartikel in der Zeitschrift American Journal of Physiology-Cell Physiology, 2025. Verfasst von Kristen D Turner und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, Michigan, United States. Hauptthemen laut MEDLINE: Pregnenediones, Muscular Dystrophy, Duchenne, Muscle, Skeletal, Cell Membrane Permeability. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: Edgewise Therapeutics, HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), NIAMS NIH HHS.
Abstract (Originalsprache)
Mechanical instability of muscle fiber membranes is a hallmark feature of Duchenne muscular dystrophy (DMD). Glucocorticoids are commonly prescribed in DMD; however, effects on contraction-induced injury and associated mechanisms remain unclear. Here, 3 wk deflazacort in mdx mice substantially reduced Evans Blue dye uptake and the lengthening contraction-induced force decline in vivo and resulted in a strong trend toward blunted calcium uptake during damaging contractions ex vivo. These findings indicate that short-term deflazacort protects from contraction-induced injury.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Molecular & Integrative Physiology, University of Michigan, Ann Arbor, Michigan, United States.
- Edgewise Therapeutics, BioFrontiers Institute, University of Colorado, Boulder, Colorado, United States.
- Department of Internal Medicine, Division of Cardiovascular Medicine, University of Michigan, Ann Arbor, Michigan, United States.
- Department of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan, United States.
ORCID-Profile: Kristen D Turner, Ying Qian, Dennis R Claflin, Angela K Peter, Daniel E Michele, Alan J Russell, Susan V Brooks
Förderung
- Edgewise Therapeutics
- HHS | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)
- NIAMS NIH HHS
- HHS | NIH | National Institute of General Medical Sciences (NIGMS)
- NIGMS NIH HHS
Zitieren
APA
Turner, K. D., Qian, Y., Claflin, D. R., Newell-Stamper, B. L., Peter, A. K., Michele, D. E., Russell, A. J., & Brooks, S. V. (2025). Short-term daily deflazacort decreases membrane permeability and increases maximum force in mdx mice. American Journal of Physiology-Cell Physiology. https://doi.org/10.1152/ajpcell.00187.2025
Vancouver
Turner KD, Qian Y, Claflin DR, Newell-Stamper BL, Peter AK, Michele DE, et al. Short-term daily deflazacort decreases membrane permeability and increases maximum force in mdx mice. American Journal of Physiology-Cell Physiology. 2025. doi:10.1152/ajpcell.00187.2025
BibTeX
@article{Turner2025,
author = {Turner, Kristen D and Qian, Ying and Claflin, Dennis R and Newell-Stamper, Breanne L and Peter, Angela K and Michele, Daniel E and Russell, Alan J and Brooks, Susan V},
title = {Short-term daily deflazacort decreases membrane permeability and increases maximum force in mdx mice},
journal = {American Journal of Physiology-Cell Physiology},
year = {2025},
doi = {10.1152/ajpcell.00187.2025}
}
EUVIMED